Orthopaedic Department, Peking University Third Hospital, Haidian District, Beijing, 100191, China; Peking University Health Science Center, 38 Xueyuan Rd, Haidian District, Beijing, 100191, China.
Department of Radiology, Peking University Third Hospital, 49 North Garden Rd, Haidian District, Beijing, 100191, China.
Spine J. 2018 Oct;18(10):1755-1762. doi: 10.1016/j.spinee.2018.02.025. Epub 2018 Mar 2.
Langerhans cell histiocytosis (LCH) of the spine is a relatively rare condition with unknown etiology. The diagnosis and treatment protocols for spine LCH remain controversial.
In this study, we evaluated the efficacy and safety of our proposed diagnosis and treatment protocol introduced in 2009.
This is a retrospective study.
A total of 110 patients with spine LCH who had been diagnosed and treated in our hospital from October 1997 to November 2015 were included in this study.
The age, gender, symptoms, neurologic function, lesion distribution, radiological features, pathology, treatment, outcome, and treatment complications of the patients were collected. Visual analog scale (VAS) for pain and Frankel scale for neurologic status were also documented.
We retrospectively reviewed 110 patients with spine LCH who had been diagnosed and treated in our hospital from October 1997 to November 2015. The indications for computed tomography (CT)-guided biopsy and surgery for spine LCH have become more stringent since 2009. In cases of a solitary spinal lesion, immobilization and observation were usually first suggested. Chemotherapy was suggested for cases with multifocal LCH lesions, and low-dosage radiotherapy was restricted to recurrent solitary lesion. This project was supported by our hospital (No. Y71508-01) (¥ 400,000).
This series included 69 male and 41 female patients (age range, 1-52 years). Pain was the most common symptom (93.6%, 103/110). Pathologic diagnosis was achieved in 72 cases (65.5%). CT-guided biopsies were performed in 91.3% (42/46) and 73.2% (41/56) of cases before and after 2009, respectively (p=.02). Ninety-eight cases (89.1%) were followed up for a mean 66.3 (range, 24-159) months. Immobilization and observation were performed in 25.9% (14/54) and 75.0% (42/56) of cases before and after 2009, respectively (p<.001). Approximately 35.2% (19/54) and 10.7% (6/56) of cases had surgery (p=.002) before and after 2009, respectively. During the follow-up, no significant difference was found in the outcomes between the two groups treated before and after 2009 (p=.64).
Biopsy is not mandatory for typical spine lesions of LCH. Given the self-healing tendency of spine LCH, immobilization and observation remain the first-choice treatments for LCH lesions. Conservative biopsy and treatment protocols might be more appropriate for spinal LCH.
朗格汉斯细胞组织细胞增生症(LCH)是一种相对罕见的疾病,病因不明。脊柱 LCH 的诊断和治疗方案仍存在争议。
本研究旨在评估我们在 2009 年提出的诊断和治疗方案的疗效和安全性。
这是一项回顾性研究。
本研究共纳入了 1997 年 10 月至 2015 年 11 月在我院诊断和治疗的 110 例脊柱 LCH 患者。
收集患者的年龄、性别、症状、神经功能、病变分布、影像学特征、病理、治疗、预后和治疗并发症。还记录了视觉模拟评分(VAS)疼痛评分和 Frankel 神经功能分级。
本研究回顾性分析了 1997 年 10 月至 2015 年 11 月在我院诊断和治疗的 110 例脊柱 LCH 患者。自 2009 年以来,脊柱 LCH 的 CT 引导活检和手术适应证更加严格。对于单发脊柱病变,通常首先建议采用固定和观察。对于多灶性 LCH 病变,建议化疗,而低剂量放疗仅限于复发性单发病变。本项目得到了我院(编号 Y71508-01)(¥400,000)的支持。
本研究共纳入 69 例男性和 41 例女性患者(年龄 1-52 岁)。疼痛是最常见的症状(93.6%,103/110)。72 例(65.5%)获得病理诊断。2009 年前和后分别有 91.3%(42/46)和 73.2%(41/56)的病例进行了 CT 引导活检(p=.02)。98 例(89.1%)患者获得平均 66.3(24-159)个月的随访。2009 年前和后分别有 25.9%(14/54)和 75.0%(42/56)的病例接受固定和观察(p<.001)。2009 年前和后分别有 35.2%(19/54)和 10.7%(6/56)的病例接受了手术(p=.002)。随访期间,两组治疗后的预后差异无统计学意义(p=.64)。
对于典型的脊柱 LCH 病变,活检并非必需。鉴于脊柱 LCH 的自愈倾向,固定和观察仍然是 LCH 病变的首选治疗方法。对于脊柱 LCH,保守的活检和治疗方案可能更为合适。